Fund Holdings — Decheng Capital LLC

Total Portfolio Value
$745.65M
Total Bought
$483.69M
Total Sold
$123.52M
Net Transaction
+$360.17M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
CG ONCOLOGY INC(CGON)05,458,810+5,458,8100239,64232.14%+239,642
Alpine Immune Sciences, Inc.7,083,2888,317,924+1,234,636135,007329,72344.22%+194,715
BeyondSpring Inc.(BYSI)4,958,1434,958,14304,45017,7012.37%+13,250
4D MOLECULAR THERAPEUTICS IN0347,835+347,835011,0821.49%+11,082
MOONLAKE IMMUNOTHERAPEUTICS0166,600+166,60008,3681.12%+8,368
CRINETICS PHARMACEUTICALS IN(CRNX)0157,958+157,95807,3940.99%+7,394
Equillium Inc.(EQ)4,447,3084,447,30803,21510,2731.38%+7,058
CYTOKINETICS INC(CYTK)094,043+94,04306,5930.88%+6,593
Illumnia, Inc.(ILMN)80,859129,067+48,20811,25917,7232.38%+6,465
LEGEND BIOTECH CORP-ADR(LEGN)086,363+86,36304,8440.65%+4,844
MERUS NV0101,798+101,79804,5840.61%+4,584
KRYSTAL BIOTECH INC(KRYS)65,77265,77208,16011,7031.57%+3,543
Zentalis Pharmaceuticals Inc.(ZNTL)2,099,5832,099,583031,80933,0894.44%+1,281
PHATHOM PHARMACEUTICALS INC(PHAT)850,000850,00007,7619,0271.21%+1,267
Pyxis Oncology, Inc (formerly Apexigen)(PYXS)326,810326,81005881,3920.19%+804
GeneDx Holdings Corp.(WGS)103,604103,60402859460.13%+661
Cue Health Inc.8,980,9098,980,90901,4591,6970.23%+238
Aadi Bioscience, Inc.(WHWK)526,329526,32901,0631,2320.17%+168
Arcus Biosciences, Inc(RCUS)869,790869,790016,61316,4222.20%-191
Aura Biosciences, Inc.(AURA)515,555515,55504,5684,0470.54%-521
AtriCure Inc.(ATRC)46,25926,797-19,4621,6518150.11%-836
Scynexis Inc.(SCYX)555,5550-555,5551,2390—-1,239
Terns Pharmaceuticals, Inc.714,2850-714,2854,6360—-4,636
LANTHEUS HOLDINGS INC(NMS)(LNTH)92,1960-92,1965,7160—-5,716
ACELYRIN INC(NSM)1,370,9510-1,370,95110,2270—-10,227
Argenx SE(ARGX)27,4290-27,42910,4350—-10,435
10x Genomics, Inc.(TXG)359,554195,835-163,71920,1217,3500.99%-12,771
ROIVANT SCIENCES LTD(ROIV)1,279,7000-1,279,70014,3710—-14,371
KARUNA THERAPEUTICS INC47,0000-47,00014,8760—-14,876
IMMUNOGEN INC659,9280-659,92819,5670—-19,567
Pacific Biosciences of California, Inc.(PACB)2,940,3610-2,940,36128,8450—-28,845
Page 1 of 1